Tyra Biosciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGTyra Biosciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 77), indicating performance broadly in line with the market. Earnings contraction of 36% provides fundamental context to the price action. Investors should exercise caution due to high volatility (61% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $29.24 | -3.13% | BELOW |
| 50 SMA | $32.84 | -13.76% | BELOW |
| 100 SMA | $33.44 | -15.31% | BELOW |
| 150 SMA | $30.34 | -6.65% | BELOW |
| 200 SMA | $26.17 | +8.20% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TYRA in an uptrend right now?
TYRA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TYRA overbought or oversold?
TYRA's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.
Is TYRA outperforming the market?
TYRA has a Relative Strength (RS) Rating of 77 out of 99. TYRA is performing about average compared to the market.
Where is TYRA in its 52-week range?
TYRA is trading at $28.32, which is 70% of its 52-week high ($40.65) and 61% above its 52-week low ($8.98).
How volatile is TYRA?
TYRA has a Beta of 0.70 and 52-week volatility of 61%. It's less volatile than the S&P 500 - generally more stable.